BTC of Lincoln — Lincoln, Rhode Island

BTC of Lincoln is a clinical research site located in Lincoln, Rhode Island, United States 02865.

Crixeo Health Trust Score: 70/100 (FAIR). This profile has not yet been claimed by the site owner.

BTC of Lincoln has participated in 5 clinical trials.

Therapeutic areas: Adult Attention Deficit Hyperactivity Disorder, Insomnia Disorder, Adjunctive Treatment of Major Depressive Disorder.

Sponsors: Otsuka Pharmaceutical Development & Commercialization, Inc., Idorsia Pharmaceuticals Ltd., ACADIA Pharmaceuticals Inc..

Sponsor Feasibility Report

Trust Score: 70/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for BTC of Lincoln?

BTC of Lincoln has a Crixeo Trust Score of 70/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has BTC of Lincoln conducted?

BTC of Lincoln has 5 clinical trials on record. Their work covers Adult Attention Deficit Hyperactivity Disorder, Insomnia Disorder, Adjunctive Treatment of Major Depressive Disorder.

Is BTC of Lincoln accredited by Crixeo Health?

Yes — BTC of Lincoln holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about BTC of Lincoln?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.